|
|
|
Insider
Information: |
Barabe Timothy C |
Relationship: |
Director |
City: |
Woburn |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
663,514 |
|
Indirect Shares
|
7,120 |
|
|
Direct
Value |
$1,614,265 |
|
|
Indirect Value
|
$142,400 |
|
|
Total
Shares |
670,634 |
|
|
Total
Value |
$1,756,665 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
5
|
Stock
price went up :
|
3
|
5
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
1.5
|
5.0
|
Percentage
Gain/Loss : |
51.6%
|
100.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2005-03-04 |
7,120 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Chief Financial Officer |
2010-02-22 |
49,570 |
2007-06-27 |
0 |
Premium* |
|
Affymetrix Inc |
AFFX |
Chief Financial Officer |
2013-03-18 |
166,378 |
|
0 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2016-11-18 |
12,910 |
2014-03-19 |
0 |
Premium* |
|
Veeva Systems Inc |
VEEV |
Director |
2021-06-22 |
6,643 |
2015-12-09 |
0 |
Premium* |
|
Selecta Biosciences Inc |
SELB |
Director |
2024-01-02 |
428,013 |
2017-03-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
252 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARQL |
Arqule Inc |
Director |
|
2008-04-30 |
4 |
B |
$3.85 |
$597 |
D/D |
155 |
14,956 |
2.31 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2012-08-19 |
4 |
D |
$3.86 |
$5,311 |
D/D |
(1,376) |
162,284 |
0 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2009-05-14 |
4 |
B |
$3.87 |
$1,200 |
D/D |
310 |
24,133 |
2.31 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2019-04-04 |
4 |
OE |
$3.87 |
$38,700 |
D/D |
10,000 |
146,897 |
0 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2009-02-18 |
4 |
B |
$3.95 |
$4,124 |
D/D |
1,044 |
23,146 |
2.31 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2008-07-17 |
4 |
B |
$3.98 |
$1,198 |
D/D |
301 |
16,846 |
2.31 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2012-08-13 |
4 |
B |
$3.99 |
$17,756 |
D/D |
4,450 |
158,110 |
2.74 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2012-08-17 |
4 |
B |
$3.99 |
$22,145 |
D/D |
5,550 |
163,660 |
2.74 |
- |
|
SELB |
Selecta Biosciences Inc |
Director |
|
2021-08-18 |
4 |
B |
$4.00 |
$36,000 |
D/D |
9,000 |
190,013 |
2.39 |
% |
|
ARQL |
Arqule Inc |
Director |
|
2008-06-17 |
4 |
B |
$4.07 |
$1,197 |
D/D |
294 |
16,545 |
2.31 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-08-20 |
4 |
B |
$4.09 |
$40,900 |
D/D |
10,000 |
80,000 |
2.74 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2008-05-15 |
4 |
B |
$4.10 |
$1,197 |
D/D |
292 |
15,248 |
2.31 |
- |
|
SELB |
Selecta Biosciences Inc |
Director |
|
2021-03-26 |
4 |
B |
$4.10 |
$41,000 |
D/D |
10,000 |
181,013 |
2.39 |
% |
|
ARQL |
Arqule Inc |
Director |
|
2008-05-29 |
4 |
B |
$4.11 |
$4,122 |
D/D |
1,003 |
16,251 |
2.31 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2009-05-18 |
4 |
B |
$4.11 |
$4,122 |
D/D |
1,003 |
25,136 |
2.31 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2010-07-15 |
4 |
A |
$4.14 |
$1,196 |
D/D |
289 |
32,869 |
0 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2008-03-25 |
4 |
B |
$4.15 |
$1,199 |
D/D |
289 |
14,801 |
2.31 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-08-19 |
4 |
A |
$4.22 |
$63,300 |
D/D |
15,000 |
70,000 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2011-08-09 |
4 |
B |
$4.25 |
$42,500 |
D/D |
10,000 |
113,150 |
2.74 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2003-07-31 |
4 |
B |
$4.26 |
$7,269 |
D/D |
1,700 |
3,700 |
2.39 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2010-08-18 |
4 |
A |
$4.26 |
$5,248 |
D/D |
1,232 |
34,239 |
0 |
- |
|
AFFX |
Affymetrix Inc |
Chief Financial Officer |
|
2010-11-19 |
4 |
B |
$4.29 |
$21,443 |
D/D |
5,000 |
85,000 |
2.74 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2010-07-28 |
4 |
A |
$4.32 |
$596 |
D/D |
138 |
33,007 |
0 |
- |
|
ARQL |
Arqule Inc |
Director |
|
2008-03-05 |
4 |
B |
$4.43 |
$598 |
D/D |
135 |
14,512 |
2.31 |
- |
|
HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
|
2008-07-01 |
4 |
B |
$4.49 |
$10,242 |
D/D |
2,281 |
24,274 |
2.74 |
- |
|
252 Records found
|
|
Page 6 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|